Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis.

Rekik S, Allaire M, Mumana A, Guyot E, Nkontchou G, Grando V, Blaise L, Ziol M, Nahon P, Ganne-Carrié N, Sutter O, Seror O, Nault JC.

J Gastroenterol Hepatol. 2020 Jan;35(1):142-150. doi: 10.1111/jgh.14763. Epub 2019 Jul 31.

PMID:
31237018
2.

Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis.

Allaire M, Rekik S, Layese R, Mumana A, Guyot E, Nkontchou G, Bourcier V, Grando V, Ziol M, Nahon P, Ganne-Carrié N, Sutter O, Audureau E, Seror O, Nault JC.

Dig Liver Dis. 2019 Jan;51(1):86-94. doi: 10.1016/j.dld.2018.07.014. Epub 2018 Jul 24.

PMID:
30126822
3.

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.

Corpechot C, Chazouillères O, Rousseau A, Le Gruyer A, Habersetzer F, Mathurin P, Goria O, Potier P, Minello A, Silvain C, Abergel A, Debette-Gratien M, Larrey D, Roux O, Bronowicki JP, Boursier J, de Ledinghen V, Heurgue-Berlot A, Nguyen-Khac E, Zoulim F, Ollivier-Hourmand I, Zarski JP, Nkontchou G, Lemoinne S, Humbert L, Rainteau D, Lefèvre G, de Chaisemartin L, Chollet-Martin S, Gaouar F, Admane FH, Simon T, Poupon R.

N Engl J Med. 2018 Jun 7;378(23):2171-2181. doi: 10.1056/NEJMoa1714519.

4.

Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan.

Roulot D, Roudot-Thoraval F, NKontchou G, Kouacou N, Costes JL, Elourimi G, Le Clesiau H, Ziol M, Beaugrand M.

Liver Int. 2017 Dec;37(12):1897-1906. doi: 10.1111/liv.13481. Epub 2017 Jul 2.

PMID:
28556413
5.

The CRP level and STATE score predict survival in cirrhotic patients with hepatocellular carcinoma treated by transarterial embolization.

Rekik S, Guyot E, Bhais M, Ajavon Y, Grando V, Bourcier V, Nkontchou G, Nahon P, Sellier N, Seror O, Ganne-Carrie N, Nault JC.

Dig Liver Dis. 2016 Sep;48(9):1088-92. doi: 10.1016/j.dld.2016.06.005. Epub 2016 Jun 15.

PMID:
27375209
6.

Percutaneous Treatment of Localized Infiltrative Hepatocellular Carcinoma Developing on Cirrhosis.

Nault JC, Nkontchou G, Nahon P, Grando V, Bourcier V, Barge S, Ziol M, Sellier N, Ganne-Carrie N, Seror O.

Ann Surg Oncol. 2016 Jun;23(6):1906-15. doi: 10.1245/s10434-015-5064-4. Epub 2016 Jan 5.

PMID:
26732275
7.

Duplication of the V3 domain in hepatitis C virus (1b) NS5A protein: Clonal analysis and physicochemical properties related to hepatocellular carcinoma occurrence.

Petsaris O, Vallet S, Le Guillou-Guillemette H, Veillon P, Gouriou S, Barbier G, Nousbaum JB, Saliou P, NKontchou G, Trinchet JC, Lunel-Fabiani F, Payan C.

J Clin Virol. 2016 Jan;74:19-25. doi: 10.1016/j.jcv.2015.11.011. Epub 2015 Dec 1.

PMID:
26655076
8.

Peripheral intrahepatic cholangiocarcinoma occurring in patients without cirrhosis or chronic bile duct diseases: epidemiology and histopathology of distant nontumoral liver in 57 White patients.

Nkontchou G, Tran Van Nhieu J, Ziol M, Tengher I, Mahmoudi A, Roulot D, Bourcier V, Ganne Carrie N, Grando-Lemaire V, Trinchet JC, Cherqui D, Beaugrand M.

Eur J Gastroenterol Hepatol. 2013 Jan;25(1):94-8. doi: 10.1097/MEG.0b013e328357cdd7.

PMID:
23085575
9.

Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis.

Nkontchou G, Aout M, Mahmoudi A, Roulot D, Bourcier V, Grando-Lemaire V, Ganne-Carrie N, Trinchet JC, Vicaut E, Beaugrand M.

Cancer Prev Res (Phila). 2012 Aug;5(8):1007-14. doi: 10.1158/1940-6207.CAPR-11-0450. Epub 2012 Apr 23.

10.

HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis.

Nkontchou G, Ziol M, Aout M, Lhabadie M, Baazia Y, Mahmoudi A, Roulot D, Ganne-Carrie N, Grando-Lemaire V, Trinchet JC, Gordien E, Vicaut E, Baghad I, Beaugrand M.

J Viral Hepat. 2011 Oct;18(10):e516-22. doi: 10.1111/j.1365-2893.2011.01441.x.

PMID:
21914071
11.

Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients.

Nkontchou G, Cosson E, Aout M, Mahmoudi A, Bourcier V, Charif I, Ganne-Carrie N, Grando-Lemaire V, Vicaut E, Trinchet JC, Beaugrand M.

J Clin Endocrinol Metab. 2011 Aug;96(8):2601-8. doi: 10.1210/jc.2010-2415. Epub 2011 Jul 13.

PMID:
21752887
12.

Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis.

Nkontchou G, Bastard JP, Ziol M, Aout M, Cosson E, Ganne-Carrie N, Grando-Lemaire V, Roulot D, Capeau J, Trinchet JC, Vicaut E, Beaugrand M.

J Hepatol. 2010 Nov;53(5):827-33. doi: 10.1016/j.jhep.2010.04.035. Epub 2010 Jul 14.

PMID:
20728234
13.

Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients.

Giannelli G, Fransvea E, Trerotoli P, Beaugrand M, Marinosci F, Lupo L, Nkontchou G, Dentico P, Antonaci S.

Clin Chim Acta. 2007 Aug;383(1-2):147-52. Epub 2007 May 26.

PMID:
17582392
14.

Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma?

Vallet S, Gouriou S, Nkontchou G, Hotta H, Vilerio M, Legrand-Quillien MC, Beaugrand M, Trinchet JC, Nousbaum JB, Dény P, Gaudy C, Goudeau A, Picard B, Payan C.

J Viral Hepat. 2007 Feb;14(2):96-106.

PMID:
17244249
15.

[Prognosis in pancolonic forms of hemorrhagic rectocolitis].

Nkontchou G, Cosnes J, Carbonnel F, Beaugerie L, Ngô Y, Malafosse M, Gendre JP, Le Quintrec Y.

Gastroenterol Clin Biol. 1996 Mar;20(2):166-71. French.

PMID:
8761676
16.

[Villonodular synovitis of the astragalo-scaphoid joint. A new case].

Nkontchou G, Gaudouen Y, Rouaud JP, Pacault JY, Amouroux J, Caroit M.

Rev Rhum Mal Osteoartic. 1992 Jan;59(1):81-2. French. No abstract available.

PMID:
1579851

Supplemental Content

Loading ...
Support Center